by palligoelme@gmail.com | Aug 20, 2025 | Clinical Trials
Conditions: AML, Adult Interventions: Drug: Daunorubicin/Idarubicin; Drug: Cytarabine; Drug: Azacitidine; Drug: Venetoclax Sponsors: Institute of Hematology & Blood Diseases Hospital, China Not yet recruiting Conditions: AML, Adult Interventions: Drug:...
by palligoelme@gmail.com | Aug 20, 2025 | Clinical Trials
Conditions: Pancreatic Cancer Interventions: Drug: HRS-4642+AG +Adebrelimab Sponsors: Ruijin Hospital; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting Conditions: Pancreatic Cancer Interventions: Drug: HRS-4642+AG +Adebrelimab Sponsors: Ruijin Hospital;...
by palligoelme@gmail.com | Aug 19, 2025 | Clinical Trials
Conditions: Hemorrhage; Hemorrhagic Shock; Upper Gastrointestinal Bleeding (UGIB) Interventions: Drug: low-titer O-group whole blood; Drug: 1:1:1 component transfusion; Drug: ABO- and Rh-compatible whole blood Sponsors: Xijing Hospital Not yet recruiting Conditions:...
by palligoelme@gmail.com | Aug 19, 2025 | Clinical Trials
Conditions: Primary Care Interventions: Behavioral: Relational Agent ( RA) Alex Sponsors: Anita Y. Kinney, PhD, RN Not yet recruiting Conditions: Primary Care Interventions: Behavioral: Relational Agent ( RA) Alex Sponsors: Anita Y. Kinney, PhD, RN Not yet...
by palligoelme@gmail.com | Aug 19, 2025 | Clinical Trials
Conditions: Distress, Psychological Interventions: Other: MBSR program Sponsors: Azienda Unita Sanitaria Locale di Piacenza; University of Siena, Italy Completed Conditions: Distress, Psychological Interventions: Other: MBSR program Sponsors: Azienda Unita Sanitaria...
by palligoelme@gmail.com | Aug 19, 2025 | Clinical Trials
Conditions: Influenza A Interventions: Biological: AZD4117; Biological: AZD5315; Other: Placebo Sponsors: AstraZeneca; Biomedical Advanced Research and Development Authority; Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear...
